Cash in looks ok for the quarter. Still like this company although the next two quarters could be interesting due to low cash. Any thoughts anyone? Would expect higher revenue as well in this next quarter due to seasonal market impacts.
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025